New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
A peptide-drug conjugate that targets the acidic environment of cancer cells may improve the efficacy of immunotherapy

A peptide-drug conjugate that targets the acidic environment of cancer cells may improve the efficacy of immunotherapy

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainA peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint
Oncology March 25,2024
A peptide-drug conjugate that targets the acidic environment of cancer cells may improve the efficacy of immunotherapy

A peptide-drug conjugate that targets the acidic environment of cancer cells may improve the efficacy of immunotherapy

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainA peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint
Oncology March 25,2024
Development of a novel bispecific antibody therapy to overcome myeloma heterogeneity

Development of a novel bispecific antibody therapy to overcome myeloma heterogeneity

by Ehime UniversityMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Multiple myeloma is still an incurable hematological ma
Oncology March 25,2024
Development of a novel bispecific antibody therapy to overcome myeloma heterogeneity

Development of a novel bispecific antibody therapy to overcome myeloma heterogeneity

by Ehime UniversityMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Multiple myeloma is still an incurable hematological ma
Oncology March 25,2024
Using phages to eradicate Pseudomonas aeruginosa infections

Using phages to eradicate Pseudomonas aeruginosa infections

FEBRUARY 21, 2024byUniversity of LiverpoolPhage cocktail screening against 551 clinical isolates. Percentage of isolates susceptible (black—complete lysis), intermediate (pink—incomplete lysis)
Public Health & Prevention March 25,2024
Using phages to eradicate Pseudomonas aeruginosa infections

Using phages to eradicate Pseudomonas aeruginosa infections

FEBRUARY 21, 2024byUniversity of LiverpoolPhage cocktail screening against 551 clinical isolates. Percentage of isolates susceptible (black—complete lysis), intermediate (pink—incomplete lysis)
Public Health & Prevention March 25,2024
Advancing the generation of in-vivo chimeric lungs in mice using rat-derived stem cells

Advancing the generation of in-vivo chimeric lungs in mice using rat-derived stem cells

JANUARY 5, 2024byNara Institute of Science and TechnologyA rat embryonic stem cells derived lung generated within a mouse body stained with epithelial cells (labeled with E-cadherin, shown in gr
Pulmonology March 25,2024
Advancing the generation of in-vivo chimeric lungs in mice using rat-derived stem cells

Advancing the generation of in-vivo chimeric lungs in mice using rat-derived stem cells

JANUARY 5, 2024byNara Institute of Science and TechnologyA rat embryonic stem cells derived lung generated within a mouse body stained with epithelial cells (labeled with E-cadherin, shown in gr
Pulmonology March 25,2024
Controlling inflammation to conquer lung infection

Controlling inflammation to conquer lung infection

JANUARY 16, 2024byHudson Institute of Medical ResearchLAT8881 and LAT9997 improve resistance to influenza A virus infection in vivo. A, Schematic of human growth hormone structure (orange; http:
Pulmonology March 25,2024
Controlling inflammation to conquer lung infection

Controlling inflammation to conquer lung infection

JANUARY 16, 2024byHudson Institute of Medical ResearchLAT8881 and LAT9997 improve resistance to influenza A virus infection in vivo. A, Schematic of human growth hormone structure (orange; http:
Pulmonology March 25,2024
A new therapeutic target turns the immune system against lymphoma

A new therapeutic target turns the immune system against lymphoma

by Ecole Polytechnique Federale de LausanneCredit: CC0 Public DomainNon-Hodgkin's lymphoma (NHL) is a group of cancers that originate in the lymph nodes and affect white blood cells of the im
Oncology March 25,2024
A new therapeutic target turns the immune system against lymphoma

A new therapeutic target turns the immune system against lymphoma

by Ecole Polytechnique Federale de LausanneCredit: CC0 Public DomainNon-Hodgkin's lymphoma (NHL) is a group of cancers that originate in the lymph nodes and affect white blood cells of the im
Oncology March 25,2024
Scientists develop a new type of anti-cancer agent

Scientists develop a new type of anti-cancer agent

JANUARY 31, 2024by Center for Research in Biological Chemistry and Molecular Materials (CiQUS)Cancer stem cells, marked in red, disappear in the presence of the reference compound (Ru1). Credit: Cente
Oncology March 25,2024
Scientists develop a new type of anti-cancer agent

Scientists develop a new type of anti-cancer agent

JANUARY 31, 2024by Center for Research in Biological Chemistry and Molecular Materials (CiQUS)Cancer stem cells, marked in red, disappear in the presence of the reference compound (Ru1). Credit: Cente
Oncology March 25,2024
New pill could prevent anaphylaxis in people with food, drug allergies

New pill could prevent anaphylaxis in people with food, drug allergies

by Northwestern UniversityCredit: CC0 Public DomainFor someone with a food or drug allergy, the risk of life-threatening anaphylactic shock lurks around every corner. A new Northwestern Medicine
Immunology & Rheumatology March 25,2024
New pill could prevent anaphylaxis in people with food, drug allergies

New pill could prevent anaphylaxis in people with food, drug allergies

by Northwestern UniversityCredit: CC0 Public DomainFor someone with a food or drug allergy, the risk of life-threatening anaphylactic shock lurks around every corner. A new Northwestern Medicine
Immunology & Rheumatology March 25,2024
Scientists discover a potential way to repair synapses damaged in Alzheimer's disease

Scientists discover a potential way to repair synapses damaged in Alzheimer's disease

FEBRUARY 1, 2024by Buck Institute for Research on AgingThe art depicts the recovery of the functional plasticity at synapses on neurons despite tau-induced toxicity in the brain. Credit: Larissa Brown
Breakthroughs March 25,2024
Scientists discover a potential way to repair synapses damaged in Alzheimer's disease

Scientists discover a potential way to repair synapses damaged in Alzheimer's disease

FEBRUARY 1, 2024by Buck Institute for Research on AgingThe art depicts the recovery of the functional plasticity at synapses on neurons despite tau-induced toxicity in the brain. Credit: Larissa Brown
Breakthroughs March 25,2024
Scientists develop an agent capable of selectively inhibiting the body's stress response

Scientists develop an agent capable of selectively inhibiting the body's stress response

JANUARY 22, 2024by Daniel Meierhans,ETH ZurichThe DEGs we identified upon 2 h, and 18 h of DEX treatments in A549 cells align with the other existing RNAseq and ChIP-seq datasets. Credit:N
Breakthroughs March 25,2024
Scientists develop an agent capable of selectively inhibiting the body's stress response

Scientists develop an agent capable of selectively inhibiting the body's stress response

JANUARY 22, 2024by Daniel Meierhans,ETH ZurichThe DEGs we identified upon 2 h, and 18 h of DEX treatments in A549 cells align with the other existing RNAseq and ChIP-seq datasets. Credit:N
Breakthroughs March 25,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com